Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
about
A novel interleukin-12 p40-related protein induced by latent Epstein-Barr virus infection in B lymphocytesNucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8)The role of interleukin-6 in cases of cardiac myxoma. Clinical features, immunologic abnormalities, and a possible role in recurrence.Signaling activities of gammaherpesvirus membrane proteinsAn Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationLatent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsInterleukin-6 functions as an intracellular growth factor in hairy cell leukemia in vitro.Epstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.Interleukin-6 and interleukin-10 gene promoter polymorphisms and risk of endemic Burkitt lymphoma.Molecular virology of Epstein-Barr virus.Impairment of natural killer functions by interleukin 6 increases lymphoblastoid cell tumorigenicity in athymic mice.Interleukin-10 inhibits apoptotic cell death in infectious mononucleosis T cellsRituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman diseaseIdentification of a sub-population of B cells that proliferates after infection with Epstein-Barr virusTheodore E. Woodward Award: development of novel, EBV-targeted therapies for EBV-positive tumorsInterleukin-6 production in posttransplant lymphoproliferative disease.Interleukin-6, but not interleukin-4, is expressed by Reed-Sternberg cells in Hodgkin's disease with or without histologic features of Castleman's diseaseCytokine production in the immune response to murine gammaherpesvirus 68.Lymphotoxin is an autocrine growth factor for Epstein-Barr virus-infected B cell lines.Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor alpha, interleukin (IL)6, IL-10, and transforming growth factor beta 1 mRNAs.Infection of human endothelial cells with Epstein-Barr virus.Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses.Epstein-Barr virus infection is common in inflamed gastrointestinal mucosa.The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation.Role of endotoxin in alterations of hepatic drug metabolism by diphtheria and tetanus toxoids and pertussis vaccine adsorbedEBV Zta protein induces the expression of interleukin-13, promoting the proliferation of EBV-infected B cells and lymphoblastoid cell lines.Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway.The role of lactic acid in autocrine B-cell growth stimulationEpstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.T cells modulate Epstein-Barr virus latency phenotypes during infection of humanized miceToll-like receptor agonists synergistically increase proliferation and activation of B cells by epstein-barr virus.A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus.Induction of interleukin-6 after stimulation of human B-cell CD21 by Epstein-Barr virus glycoproteins gp350 and gp220.The replication and transcription activator of murine gammaherpesvirus 68 cooperatively enhances cytokine-activated, STAT3-mediated gene expression.Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.Infection of peripheral blood mononuclear cells by herpes simplex and Epstein-Barr viruses. Differential induction of interleukin 6 and tumor necrosis factor-alphaDistribution and phenotype of Epstein-Barr virus-infected cells in inflammatory bowel disease.VEGF and IHH rescue definitive hematopoiesis in Gata-4 and Gata-6-deficient murine embryoid bodies.EBV Positive Diffuse Large B Cell Lymphoma and Chronic Lymphocytic Leukemia Patients Exhibit Increased Anti-dUTPase Antibodies.
P2860
Q24315666-BA203CA0-EB79-4A8A-872E-1D38760B12BBQ24650427-9BFECF07-683A-4DF7-9079-2879C74C3DBFQ33581429-575F8E17-DC73-43C2-B171-D9E228A78735Q33822504-23E4BEF8-FD64-461A-9905-B85B00CA391FQ33825713-4CAC6A18-5FCE-4A5D-9E2D-8CF97F838234Q33891012-F691D277-DC7E-49A1-B403-0977671661B2Q33907983-137C1DF9-B62A-4828-A027-0ECDA481B933Q34123985-66D53FED-B247-480C-B64E-981AED8D2FABQ34138588-A37B818D-4642-45A4-BAF8-056F69A0A10BQ34225554-680FB9FC-3912-4196-A626-562B5F6A4E35Q34225642-365C3326-2AA3-48E3-91EB-FF4A2382DDE0Q34235308-68BE25E5-1823-4C79-932B-4246A184CE8BQ34636851-A867CCC8-1520-42C8-8F02-737DF88B81EAQ34668808-91E1CC52-0217-4881-B19D-C280F635392DQ34767204-2DAD354A-4B38-42FB-A0A1-EFDCDE2B65B6Q35611724-57325387-C24A-48C1-A96A-755A5B30B922Q35831873-BCF8A79D-423D-44AD-82BA-15E2BD7209C2Q35860661-001E9602-4A8E-4267-AE07-0346E6E8C283Q36361402-682755C9-E41D-483E-9F04-55908388D287Q36362064-1CDE4D2A-370C-4113-9F8B-D8135AA0C990Q36365385-97C2C1D6-C0AA-42AC-AD8F-128930A86857Q36404230-A583D4EC-62D9-4A81-88DC-DC78D8021650Q36503818-67D837F1-0055-43EC-96C8-93176DB07136Q36828608-B258BEF9-E230-4C25-AB32-94E1E1D18DB7Q36950755-CA838B80-9F29-49A1-A5A9-C9CAB650A2BEQ37262460-29B0EEBB-B07F-4919-854D-83A8B799713BQ37595549-37FC6CD8-731A-423C-A83A-4168E10E3DDCQ37640575-8684AD46-1030-4F7C-A0DD-5794BEF50508Q38319697-17791ACE-791B-46BF-86C8-68BAD8F89DCCQ38326876-17094DCB-66F5-4489-925B-B520A26C3143Q39609877-32C8BA64-7546-49E2-B2E5-069C84F6F855Q39736828-7ECC4A3C-A8A5-4748-BD60-03070226ED23Q39873174-7882EEFF-C8C1-4496-8C88-CB26D0E8A3D0Q40077951-049CD537-FFD9-458D-B77C-0D48A313D72EQ40096496-5C524021-3181-4676-A017-99D3576A5F4DQ40343714-BAFBDDA5-1CD6-4D2F-AF1F-5B2A3E81C2D0Q42051276-4A354F50-5931-4154-9271-2E1A46EC43D6Q43068971-55C13F59-9E88-499C-9935-A83EFB6EE840Q54221806-5C351C91-EDAE-47A0-86B9-1A722EBCB832
P2860
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Identification of interleukin- ...... rr virus-immortalized B cells.
@ast
Identification of interleukin- ...... rr virus-immortalized B cells.
@en
type
label
Identification of interleukin- ...... rr virus-immortalized B cells.
@ast
Identification of interleukin- ...... rr virus-immortalized B cells.
@en
prefLabel
Identification of interleukin- ...... rr virus-immortalized B cells.
@ast
Identification of interleukin- ...... rr virus-immortalized B cells.
@en
P2093
P2860
P1433
P1476
Identification of interleukin- ...... rr virus-immortalized B cells.
@en
P2093
P2860
P304
P407
P577
1990-06-01T00:00:00Z